Related Articles
Interleukin‑6 induces an epithelial‑mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration
MMP12 is a potential therapeutic target for Adamantinomatous craniopharyngioma: Conclusions from bioinformatics analysis and <em>in vitro</em> experiments
miR‑125/CDK2 axis in cochlear progenitor cell proliferation
Expression of S100A9 in adamantinomatous craniopharyngioma and its association with wet keratin formation
Comparison of neuroendocrine dysfunction in patients with adamantinomatous and papillary craniopharyngiomas